HRT · Supply chain
Estrogen patch shortage: alternatives and what to do
Estradiol transdermal patch shortages have affected multiple brands and doses over the past several years. If your patch is unavailable, there are equally effective alternatives — gels, sprays, oral estradiol, and compounded transdermal formulations. Switching requires a brief conversation with your prescriber.
Alternatives that work
- Estradiol gel — Divigel, Estrogel, Elestrin. Daily application to thigh or arm.
- Estradiol spray (Evamist) — daily inner-forearm spray.
- Compounded transdermal cream — flexible dosing, must be from a reputable compounding pharmacy.
- Oral estradiol — effective but carries a small clotting risk; reasonable short-term bridge.
Switching safely
Do not stop HRT abruptly waiting for a patch to return — symptoms and bone loss resume quickly. Contact your prescriber for a same-day switch to gel or spray. Most menopause-trained clinicians can call in a substitute within one visit.
What to avoid
Do not double up on old patches. Do not source estradiol from unverified online pharmacies. Do not switch to phytoestrogen supplements expecting equivalent effect — the pharmacology is different.
Frequently asked questions
Why is there an estrogen patch shortage?
Manufacturing constraints, adhesive supply issues, and unexpected demand growth have all contributed. Multiple manufacturers have reported intermittent outages across dose strengths.
What can I take instead of an estradiol patch?
Estradiol gel (Divigel, Estrogel, Elestrin), estradiol spray (Evamist), oral estradiol (Estrace), or compounded transdermal cream. All deliver equivalent estradiol when dosed properly.
How do you convert a patch dose to gel?
Approximate equivalents: 0.05 mg/day patch ≈ 1.25 g gel daily (Estrogel) or 1 g Divigel. Your prescriber will fine-tune based on symptoms.
Is oral estradiol the same as the patch?
Similar symptom relief, but oral has first-pass liver metabolism which raises clotting factors. Transdermal is preferred for women with cardiovascular risk factors.
When will the estrogen patch shortage end?
Supply is intermittent and manufacturer-dependent. Check FDA drug shortages database for current status. Most pharmacies can source alternative brands within 1–2 weeks.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.